Certain proteins, such as insulin, TTR, amyloid-beta, etc, can aggregate in our bodies into amyloid deposits. They accompany diseases such as Alzheimers, Parkinson’s disease and can also be a problem for diabetes patients. Together with protein chemist and molecular designers we develop new probes that fluoresce and can report on the presence and status of such aggregates. We study in vitro protein systems and samples from animal models. Recently, we are starting up experiments with cells. The activity is tightly connected to the ‘biophotonics lab’ using the molecular imaging platforms at NTNU/IFY.